OCHSNER LSU HEALTH MONROE — History
CCN 190011 | 3-year financial timeline | COVID resilience: 20/100
🛡️ Public data only — no PHI permitted on this instance.
$85M
Latest Revenue (FY2022)
-4.2%
Revenue CAGR (3yr)
-100.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $93M | $81M | $85M | +5.7% | -4.2% |
| Operating Expenses | $145M | $164M | $170M | +3.9% | +8.5% |
| Operating Margin | -56.2% | -100.0% | -100.0% | +0.0% | +0.0% |
| Net Income | $-52M | $-84M | $-85M | -2.3% | +0.0% |
| Licensed Beds | 94 | 85 | 84 | -1.2% | -5.5% |
| Total Patient Days | 20,170 | 18,216 | 19,433 | +6.7% | -1.8% |
| Medicare Day % | 14% | 12% | 9% | -23.4% | -20.6% |
| Medicaid Day % | 4% | 5% | 3% | -38.0% | -11.1% |
COVID Impact & Recovery
Resilience Score: 20/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -8.2% ($93M → $85M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-4.2%
This Hospital
+7.6%
State Avg
Latest Margin
-100.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $81M | -121.9% |
| FY2024 (proj) | $77M | -143.8% |
| FY2025 (proj) | $74M | -165.6% |